Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021

Upgrades

• For Cerecor Inc CERC, Maxim Group upgraded the previous rating of Hold to Buy. In the fourth quarter, Cerecor showed an EPS of $0.19, compared to $0.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.50 and a 52-week-low of $1.97. Cerecor closed at $2.34 at the end of the last trading period.
• Berenberg upgraded the previous rating for Mattel Inc MAT from Hold to Buy. In the fourth quarter, Mattel showed an EPS of $0.40, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $21.87 and a 52-week-low of $7.54. At the end of the last trading period, Mattel closed at $20.47.
• B of A Securities upgraded the previous rating for First Solar Inc FSLR from Underperform to Neutral. First Solar earned $1.08 in the fourth quarter, compared to $2.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $112.50 and a 52-week-low of $37.92. First Solar closed at $79.36 at the end of the last trading period.
• For UnitedHealth Group Inc UNH, Argus Research upgraded the previous rating of Hold to Buy. For the first quarter, UnitedHealth Group had an EPS of $5.31, compared to year-ago quarter EPS of $3.72. At the moment, the stock has a 52-week-high of $397.88 and a 52-week-low of $273.25. UnitedHealth Group closed at $396.76 at the end of the last trading period.
• According to Jefferies, the prior rating for CRISPR Therapeutics AG CRSP was changed from Hold to Buy. In the fourth quarter, CRISPR Therapeutics showed an EPS of $1.50, compared to $0.51 from the year-ago quarter. The current stock performance of CRISPR Therapeutics shows a 52-week-high of $220.20 and a 52-week-low of $46.84. Moreover, at the end of the last trading period, the closing price was at $121.67.
• According to UBS, the prior rating for PepsiCo Inc PEP was changed from Neutral to Buy. For the first quarter, PepsiCo had an EPS of $1.21, compared to year-ago quarter EPS of $1.07. The current stock performance of PepsiCo shows a 52-week-high of $148.77 and a 52-week-low of $126.53. Moreover, at the end of the last trading period, the closing price was at $145.71.
• Truist Securities upgraded the previous rating for Bonanza Creek Energy Inc BCEI from Hold to Buy. For the fourth quarter, Bonanza Creek Energy had an EPS of $0.79, compared to year-ago quarter EPS of $0.28. The current stock performance of Bonanza Creek Energy shows a 52-week-high of $40.79 and a 52-week-low of $11.88. Moreover, at the end of the last trading period, the closing price was at $29.90.
• For Intuitive Surgical Inc ISRG, Oppenheimer upgraded the previous rating of Underperform to Perform. In the first quarter, Intuitive Surgical showed an EPS of $3.52, compared to $2.69 from the year-ago quarter. The stock has a 52-week-high of $826.81 and a 52-week-low of $488.00. At the end of the last trading period, Intuitive Surgical closed at $811.11.
• According to Deutsche Bank, the prior rating for Copa Holdings SA CPA was changed from Hold to Buy. Copa Holdings earned $2.00 in the fourth quarter, compared to $2.17 in the year-ago quarter. The stock has a 52-week-high of $94.91 and a 52-week-low of $35.16. At the end of the last trading period, Copa Holdings closed at $75.69.
• According to Stifel, the prior rating for Netflix Inc NFLX was changed from Hold to Buy. For the first quarter, Netflix had an EPS of $3.75, compared to year-ago quarter EPS of $1.57. The stock has a 52-week-high of $593.29 and a 52-week-low of $393.60. At the end of the last trading period, Netflix closed at $549.57.
• Berenberg upgraded the previous rating for Morgan Stanley MS from Hold to Buy. Morgan Stanley earned $2.22 in the first quarter, compared to $0.99 in the year-ago quarter. The current stock performance of Morgan Stanley shows a 52-week-high of $86.64 and a 52-week-low of $35.53. Moreover, at the end of the last trading period, the closing price was at $77.30.
• According to Baird, the prior rating for Intuitive Surgical Inc ISRG was changed from Neutral to Outperform. Intuitive Surgical earned $3.52 in the first quarter, compared to $2.69 in the year-ago quarter. The stock has a 52-week-high of $826.81 and a 52-week-low of $488.00. At the end of the last trading period, Intuitive Surgical closed at $811.11.
• For CSX Corp CSX, BMO Capital upgraded the previous rating of Market Perform to Outperform. CSX earned $0.93 in the first quarter, compared to $1.00 in the year-ago quarter. The stock has a 52-week-high of $101.35 and a 52-week-low of $58.80. At the end of the last trading period, CSX closed at $98.45.
• Jefferies upgraded the previous rating for Citrix Systems Inc CTXS from Hold to Buy. In the fourth quarter, Citrix Systems showed an EPS of $1.46, compared to $1.71 from the year-ago quarter. At the moment, the stock has a 52-week-high of $173.56 and a 52-week-low of $111.26. Citrix Systems closed at $138.12 at the end of the last trading period.
• For FirstEnergy Corp FE, Keybanc upgraded the previous rating of Sector Weight to Overweight. For the fourth quarter, FirstEnergy had an EPS of $0.32, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $45.82 and a 52-week-low of $22.85. At the end of the last trading period, FirstEnergy closed at $36.29.
• According to Goldman Sachs, the prior rating for Norwegian Cruise Line Holdings Ltd NCLH was changed from Neutral to Buy. In the fourth quarter, Norwegian Cruise Line showed an EPS of $2.33, compared to $0.73 from the year-ago quarter. At the moment, the stock has a 52-week-high of $34.48 and a 52-week-low of $9.24. Norwegian Cruise Line closed at $26.72 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

• According to B of A Securities, the prior rating for AutoZone Inc AZO was changed from Neutral to Underperform. In the second quarter, AutoZone showed an EPS of $14.93, compared to $12.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $1524.98 and a 52-week-low of $972.93. AutoZone closed at $1513.11 at the end of the last trading period.
• For Mr. Cooper Group Inc COOP, Barclays downgraded the previous rating of Overweight to Equal-Weight. In the fourth quarter, Mr. Cooper Group showed an EPS of $2.00, compared to $0.78 from the year-ago quarter. The stock has a 52-week-high of $37.91 and a 52-week-low of $7.33. At the end of the last trading period, Mr. Cooper Group closed at $32.02.
• B of A Securities downgraded the previous rating for Rocket Companies Inc RKT from Buy to Neutral. Rocket Companies earned $1.14 in the fourth quarter. The stock has a 52-week-high of $43.00 and a 52-week-low of $17.78. At the end of the last trading period, Rocket Companies closed at $21.67.
• According to Barclays, the prior rating for loanDepot Inc LDI was changed from Overweight to Equal-Weight. At the moment, the stock has a 52-week-high of $39.85 and a 52-week-low of $14.00. loanDepot closed at $18.69 at the end of the last trading period.
• According to UBS, the prior rating for Freeport-McMoRan Inc FCX was changed from Buy to Neutral. Freeport-McMoRan earned $0.39 in the fourth quarter, compared to $0.02 in the year-ago quarter. The current stock performance of Freeport-McMoRan shows a 52-week-high of $39.10 and a 52-week-low of $7.30. Moreover, at the end of the last trading period, the closing price was at $35.87.
• Stephens & Co. downgraded the previous rating for First Midwest Bancorp Inc FMBI from Overweight to Equal-Weight. For the first quarter, First Midwest Bancorp had an EPS of $0.37, compared to year-ago quarter EPS of $0.22. At the moment, the stock has a 52-week-high of $24.28 and a 52-week-low of $10.31. First Midwest Bancorp closed at $20.87 at the end of the last trading period.
• According to Deutsche Bank, the prior rating for Jack In The Box Inc JACK was changed from Buy to Hold. In the first quarter, Jack In The Box showed an EPS of $2.16, compared to $1.17 from the year-ago quarter. The stock has a 52-week-high of $121.81 and a 52-week-low of $52.11. At the end of the last trading period, Jack In The Box closed at $117.27.
• According to Raymond James, the prior rating for Pinnacle Financial Partners Inc PNFP was changed from Outperform to Market Perform. In the first quarter, Pinnacle Finl Partners showed an EPS of $1.61, compared to $0.39 from the year-ago quarter. The stock has a 52-week-high of $96.52 and a 52-week-low of $31.84. At the end of the last trading period, Pinnacle Finl Partners closed at $84.80.
• According to UBS, the prior rating for Southern Copper Corp SCCO was changed from Neutral to Sell. Southern Copper earned $0.76 in the fourth quarter, compared to $0.40 in the year-ago quarter. The current stock performance of Southern Copper shows a 52-week-high of $83.15 and a 52-week-low of $28.05. Moreover, at the end of the last trading period, the closing price was at $71.33.
• According to Raymond James, the prior rating for Allison Transmission Holdings Inc ALSN was changed from Strong Buy to Market Perform. In the fourth quarter, Allison Transmission showed an EPS of $0.53, compared to $0.85 from the year-ago quarter. At the moment, the stock has a 52-week-high of $46.04 and a 52-week-low of $31.69. Allison Transmission closed at $44.09 at the end of the last trading period.
• For J2 Global Inc JCOM, Piper Sandler downgraded the previous rating of Overweight to Neutral. J2 Global earned $3.11 in the fourth quarter, compared to $2.38 in the year-ago quarter. The stock has a 52-week-high of $135.24 and a 52-week-low of $53.24. At the end of the last trading period, J2 Global closed at $129.36.
• Morgan Stanley downgraded the previous rating for Zebra Technologies Corp ZBRA from Equal-Weight to Underweight. Zebra Technologies earned $4.46 in the fourth quarter, compared to $3.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $518.66 and a 52-week-low of $192.42. Zebra Technologies closed at $499.56 at the end of the last trading period.
• Citigroup downgraded the previous rating for Procter & Gamble Co PG from Buy to Neutral. For the third quarter, Procter & Gamble had an EPS of $1.26, compared to year-ago quarter EPS of $1.17. The current stock performance of Procter & Gamble shows a 52-week-high of $146.92 and a 52-week-low of $111.25. Moreover, at the end of the last trading period, the closing price was at $137.77.
• According to DZ Bank, the prior rating for Oracle Corp ORCL was changed from Buy to Hold. For the third quarter, Oracle had an EPS of $1.16, compared to year-ago quarter EPS of $0.97. At the moment, the stock has a 52-week-high of $80.21 and a 52-week-low of $50.86. Oracle closed at $79.22 at the end of the last trading period.
• For Portland General Electric Co POR, Keybanc downgraded the previous rating of Overweight to Sector Weight. In the fourth quarter, Portland General Electric showed an EPS of $0.57, compared to $0.68 from the year-ago quarter. The current stock performance of Portland General Electric shows a 52-week-high of $51.50 and a 52-week-low of $31.96. Moreover, at the end of the last trading period, the closing price was at $51.45.
• According to Keybanc, the prior rating for Eversource Energy ES was changed from Overweight to Sector Weight. For the fourth quarter, Eversource Energy had an EPS of $0.85, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of $96.66 and a 52-week-low of $73.61. Eversource Energy closed at $90.59 at the end of the last trading period.
• Keybanc downgraded the previous rating for DTE Energy Co DTE from Overweight to Sector Weight. DTE Energy earned $1.39 in the fourth quarter, compared to $1.35 in the year-ago quarter. The current stock performance of DTE Energy shows a 52-week-high of $141.98 and a 52-week-low of $92.39. Moreover, at the end of the last trading period, the closing price was at $141.75.

See all analyst ratings downgrades.

Initiations

• Craig-Hallum initiated coverage on Fennec Pharmaceuticals Inc FENC with a Buy rating. The price target for Fennec Pharmaceuticals is set to $17.00. For the fourth quarter, Fennec Pharmaceuticals had an EPS of $0.13, compared to year-ago quarter EPS of $0.18. The current stock performance of Fennec Pharmaceuticals shows a 52-week-high of $10.67 and a 52-week-low of $4.80. Moreover, at the end of the last trading period, the closing price was at $6.22.
• Roth Capital initiated coverage on PureCycle Technologies Inc PCT with a Buy rating. The price target for PureCycle Technologies is set to $45.00. At the moment, the stock has a 52-week-high of $35.75 and a 52-week-low of $22.43. PureCycle Technologies closed at $23.15 at the end of the last trading period.
• With a Buy rating, B of A Securities initiated coverage on Molecular Templates Inc MTEM. The price target seems to have been set at $12.00 for Molecular Templates. In the fourth quarter, Molecular Templates showed an EPS of $0.53, compared to $0.41 from the year-ago quarter. The current stock performance of Molecular Templates shows a 52-week-high of $18.44 and a 52-week-low of $7.51. Moreover, at the end of the last trading period, the closing price was at $7.96.
• B of A Securities initiated coverage on Archer-Daniels Midland Co ADM with a Buy rating. The price target for Archer-Daniels Midland is set to $68.00. For the fourth quarter, Archer-Daniels Midland had an EPS of $1.21, compared to year-ago quarter EPS of $1.42. The current stock performance of Archer-Daniels Midland shows a 52-week-high of $59.74 and a 52-week-low of $33.01. Moreover, at the end of the last trading period, the closing price was at $58.70.
• With a Hold rating, Truist Securities initiated coverage on Hims & Hers Health Inc HIMS. The price target seems to have been set at $12.00 for Hims & Hers Health. In the fourth quarter, Hims & Hers Health showed an EPS of $0.07, compared to $0.16 from the year-ago quarter. The current stock performance of Hims & Hers Health shows a 52-week-high of $25.40 and a 52-week-low of $9.87. Moreover, at the end of the last trading period, the closing price was at $9.88.
• With a Neutral rating, B of A Securities initiated coverage on Bunge Ltd BG. The price target seems to have been set at $88.00 for Bunge. Bunge earned $3.05 in the fourth quarter, compared to $1.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $83.89 and a 52-week-low of $32.68. Bunge closed at $81.19 at the end of the last trading period.
• Truist Securities initiated coverage on Arvinas Inc ARVN with a Buy rating. The price target for Arvinas is set to $150.00. Arvinas earned $0.99 in the fourth quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $92.77 and a 52-week-low of $19.68. Arvinas closed at $61.91 at the end of the last trading period.
• With an Overweight rating, Cantor Fitzgerald initiated coverage on 89bio Inc ETNB. The price target seems to have been set at $58.00 for 89bio. For the fourth quarter, 89bio had an EPS of $0.63, compared to year-ago quarter EPS of $2.58. At the moment, the stock has a 52-week-high of $42.36 and a 52-week-low of $18.01. 89bio closed at $25.81 at the end of the last trading period.
• With a Neutral rating, Citigroup initiated coverage on Conagra Brands Inc CAG. The price target seems to have been set at $42.00 for Conagra Brands. For the third quarter, Conagra Brands had an EPS of $0.59, compared to year-ago quarter EPS of $0.47. The stock has a 52-week-high of $39.34 and a 52-week-low of $31.66. At the end of the last trading period, Conagra Brands closed at $38.27.
• Loop Capital initiated coverage on E2open Parent Holdings Inc ETWO with a Buy rating. The price target for E2open Parent Holdings is set to $13.00. At the moment, the stock has a 52-week-high of $11.20 and a 52-week-low of $8.26. E2open Parent Holdings closed at $9.60 at the end of the last trading period.
• With a Buy rating, UBS initiated coverage on Equitable Holdings Inc EQH. The price target seems to have been set at $44.00 for Equitable Holdings. Equitable Holdings earned $1.65 in the fourth quarter, compared to $1.37 in the year-ago quarter. The current stock performance of Equitable Holdings shows a 52-week-high of $34.22 and a 52-week-low of $14.08. Moreover, at the end of the last trading period, the closing price was at $32.62.
• With a Buy rating, UBS initiated coverage on MetLife Inc MET. The price target seems to have been set at $72.00 for MetLife. For the fourth quarter, MetLife had an EPS of $2.03, compared to year-ago quarter EPS of $1.98. At the moment, the stock has a 52-week-high of $63.60 and a 52-week-low of $29.18. MetLife closed at $61.16 at the end of the last trading period.
• UBS initiated coverage on Aflac Inc AFL with a Neutral rating. The price target for Aflac is set to $55.00. For the fourth quarter, Aflac had an EPS of $1.07, compared to year-ago quarter EPS of $1.03. At the moment, the stock has a 52-week-high of $53.71 and a 52-week-low of $30.32. Aflac closed at $52.53 at the end of the last trading period.
• With a Neutral rating, UBS initiated coverage on Lincoln National Corp LNC. The price target seems to have been set at $67.00 for Lincoln National. Lincoln National earned $1.78 in the fourth quarter, compared to $2.41 in the year-ago quarter. The stock has a 52-week-high of $67.37 and a 52-week-low of $26.97. At the end of the last trading period, Lincoln National closed at $62.43.
• UBS initiated coverage on Prudential Financial Inc PRU with a Neutral rating. The price target for Prudential Financial is set to $96.00. For the fourth quarter, Prudential Financial had an EPS of $2.93, compared to year-ago quarter EPS of $2.33. At the moment, the stock has a 52-week-high of $99.87 and a 52-week-low of $48.52. Prudential Financial closed at $96.02 at the end of the last trading period.
• Rosenblatt initiated coverage on Coinbase Global Inc COIN with a Buy rating. The price target for Coinbase Global is set to $450.00. At the moment, the stock has a 52-week-high of $429.54 and a 52-week-low of $310.00. Coinbase Global closed at $320.82 at the end of the last trading period.
• B. Riley FBR initiated coverage on INmune Bio Inc INMB with a Buy rating. The price target for INmune Bio is set to $29.00. In the fourth quarter, INmune Bio showed an EPS of $0.24, compared to $0.22 from the year-ago quarter. The current stock performance of INmune Bio shows a 52-week-high of $29.99 and a 52-week-low of $4.03. Moreover, at the end of the last trading period, the closing price was at $11.02.
• Jefferies initiated coverage on Ballys Corp BALY with a Buy rating. The price target for Ballys is set to $66.00. For the fourth quarter, Ballys had an EPS of $0.39, compared to year-ago quarter EPS of $0.42. At the moment, the stock has a 52-week-high of $75.92 and a 52-week-low of $29.30. Ballys closed at $54.73 at the end of the last trading period.
• HC Wainwright & Co. initiated coverage on Addex Therapeutics Ltd ADXN with a Buy rating. The price target for Addex Therapeutics is set to $28.00. Interestingly, in the fourth quarter, Addex Therapeutics's EPS was $0.09. The stock has a 52-week-high of $37.52 and a 52-week-low of $6.24. At the end of the last trading period, Addex Therapeutics closed at $10.13.
• With a Buy rating, HC Wainwright & Co. initiated coverage on Aclaris Therapeutics Inc ACRS. The price target seems to have been set at $40.00 for Aclaris Therapeutics. Aclaris Therapeutics earned ($0.30) in the fourth quarter, compared to ($0.45) in the year-ago quarter. The stock has a 52-week-high of $30.38 and a 52-week-low of $1.02. At the end of the last trading period, Aclaris Therapeutics closed at $26.46.
• With an Outperform rating, Telsey Advisory Group initiated coverage on Bespoke Capital Acquisition Corp BSPE. The price target seems to have been set at $15.00 for Bespoke Capital Acq. The current stock performance of Bespoke Capital Acq shows a 52-week-high of $11.37 and a 52-week-low of $9.65. Moreover, at the end of the last trading period, the closing price was at $10.02.

See all analyst ratings initiations.